Application of the WHO Reporting System for Soft Tissue Cytopathology in Bone and Soft Tissue FNAs : Diagnostic Accuracy and Risk of Malignancy Analysis
Diagnostic Cytopathology · 2026
DOI: 10.1002/dc.70181 ↗At a glance
Journal article in Diagnostic Cytopathology, 2026. Written by Senay Erdogan-Durmus and 4 co-authors. Institution: Department of Pathology, Cytopathology Division, University of Health Sciences, İzmir City Hospital, İzmir, Turkey. Major MEDLINE topics: Soft Tissue Neoplasms, Bone Neoplasms, Bone and Bones. 21 references.
Abstract (original language)
Introduction
Recently, a standardized reporting system for soft tissue cytopathology was introduced. The aim is to evaluate the diagnostic utility of FNA in the diagnosis of bone and soft tissue lesions by comparing the cytological and histopathological diagnoses in a large group of cases and to determine the risk of malignancy (ROM) rates according to the World Health Organization (WHO) Reporting System for Soft Tissue Cytopathology. Materials and Methods The pathology databases were searched for cases that underwent FNA for bone and soft tissue lesions between 2020 and 2023. Only cases that had available histological follow‐up were included. The FNAs are categorized as nondiagnostic (ND), benign, atypical, soft tissue neoplasm of uncertain malignant potential (STNUMP), suspicious for malignancy (SM), malignant (primary/metastatic) according to WHO Reporting System for Soft Tissue Cytopathology. The risk of malignancy (ROM) was calculated for each group.
Results
The study consisted of 427 cases, including 30 ND (7%), 322 benign (75.4%), 19 atypical (4.5%), 7 STNUMP (1.6%), 5 SM (1.2%), and 44 malignant (10.3%). The ROM rates were 16.6%, 1.8%, 57.9%, 28.5%, 80%, and 100% for the groups: ND, benign, atypical, STNUMP, SM, and malignant, respectively. The diagnostic accuracy, sensitivity, and specificity of FNA in all bone and soft tissue lesions were 98.6%, 92.3%, and 100%, respectively.
Conclusion
We conclude that FNA is a simple and accurate technique for assessment of bone and soft tissue lesions. The WHO Soft Tissue Cytopathology Reporting System could improve communication among pathologists and clinicians, simplify clinical management of patients, and support further research in soft tissue cytology.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pathology, Cytopathology Division, University of Health Sciences, İzmir City Hospital, İzmir, Turkey.
- Department of Pathology, University of Health Sciences, Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul, Turkey.
- Department of Orthopedics, University of Health Sciences, Baltalimani Bone Diseases Training and Research Hospital, İstanbul, Turkey.
ORCID profiles: Senay Erdogan-Durmus, Sila Ozlem Aktas-Senkaya, Rahime Tanritanir, Muhammet Coskun Arslan, Cem Comunoglu
Cite
APA
Erdogan-Durmus, S., Aktas-Senkaya, S. O., Tanritanir, R., Arslan, M. C., & Comunoglu, C. (2026). Application of the WHO Reporting System for Soft Tissue Cytopathology in Bone and Soft Tissue FNAs : Diagnostic Accuracy and Risk of Malignancy Analysis. Diagnostic Cytopathology. https://doi.org/10.1002/dc.70181
Vancouver
Erdogan-Durmus S, Aktas-Senkaya SO, Tanritanir R, Arslan MC, Comunoglu C. Application of the WHO Reporting System for Soft Tissue Cytopathology in Bone and Soft Tissue FNAs : Diagnostic Accuracy and Risk of Malignancy Analysis. Diagnostic Cytopathology. 2026. doi:10.1002/dc.70181
BibTeX
@article{ErdoganDurmus2026,
author = {Erdogan-Durmus, Senay and Aktas-Senkaya, Sila Ozlem and Tanritanir, Rahime and Arslan, Muhammet Coskun and Comunoglu, Cem},
title = {Application of the WHO Reporting System for Soft Tissue Cytopathology in Bone and Soft Tissue FNAs : Diagnostic Accuracy and Risk of Malignancy Analysis},
journal = {Diagnostic Cytopathology},
year = {2026},
doi = {10.1002/dc.70181}
}
EUVIMED